MAGNESIUM SULFATE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for magnesium sulfate and what is the scope of freedom to operate?
Magnesium sulfate
is the generic ingredient in twelve branded drugs marketed by B Braun Medical Inc, Baxter Hlthcare Corp, Fresenius Kabi Usa, Hospira, Hq Spclt Pharma, Mylan Labs Ltd, Amneal, Gland Pharma Ltd, Milla Pharms, Exela Pharma, Braintree Labs, Baxter Hlthcare, Gator Pharms, Taro, Alkem Labs Ltd, Novel Labs Inc, and Strides Pharma, and is included in thirty NDAs. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.There are nine drug master file entries for magnesium sulfate. Seventeen suppliers are listed for this compound. There is one tentative approval for this compound.
Summary for MAGNESIUM SULFATE
| US Patents: | 4 |
| Tradenames: | 12 |
| Applicants: | 17 |
| NDAs: | 30 |
| Drug Master File Entries: | 9 |
| Finished Product Suppliers / Packagers: | 17 |
| Raw Ingredient (Bulk) Api Vendors: | 137 |
| Clinical Trials: | 314 |
| Patent Applications: | 1,386 |
| Formulation / Manufacturing: | see details |
| What excipients (inactive ingredients) are in MAGNESIUM SULFATE? | MAGNESIUM SULFATE excipients list |
| DailyMed Link: | MAGNESIUM SULFATE at DailyMed |
Recent Clinical Trials for MAGNESIUM SULFATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Cukurova University | Phase 4 |
| Southeastern Ontario Academic Medical Organization (SEAMO) | Phase 4 |
| Brigham and Women's Hospital | Phase 2 |
Generic filers with tentative approvals for MAGNESIUM SULFATE
| Applicant | Application No. | Strength | Dosage Form |
| ⤷ Try a Trial | ⤷ Try a Trial | 1.6GM/BOT; 3.13GM/BOT; 17.5GM/BOT | SOLUTION;ORAL |
The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.
